BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4275697)

  • 1. Lymphocyte stimulation by phytohemagglutinin and tumor cells of malignant effusions.
    Robinson E; Sher S; Mekori T
    Cancer Res; 1974 Jul; 34(7):1548-51. PubMed ID: 4275697
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth-inhibition effect of lymph-node cells from cancer patients on autochthonous tumor cell.
    Orita K; Kobayashi M; Konaga E; Kolumai Y; Hiramatsu M
    Acta Med Okayama; 1973 Dec; 27(5):133-40. PubMed ID: 4273582
    [No Abstract]   [Full Text] [Related]  

  • 3. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
    Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
    Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High Ca 125 serum level in benign ascites or pleural effusion].
    Mezger J; Häussinger KE; Wilmanns W; Lamerz R
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):463-5. PubMed ID: 3476336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed lymphocyte--tumor cell culture reaction in cancer patients.
    Ikeda H; Toge T; Niimoto M; Hattori T
    Gan; 1978 Jun; 69(3):417-21. PubMed ID: 149686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte blastogenic responses to cultured allogeneic tumor cells in vitro.
    Anderson RJ; McBride CM; Hersh EM
    Cancer Res; 1972 May; 32(5):988-92. PubMed ID: 4336032
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunosuppression: a paraneoplastic syndrome].
    Nagel GA
    Schweiz Med Wochenschr; 1971 Apr; 101(13):470-4. PubMed ID: 5283773
    [No Abstract]   [Full Text] [Related]  

  • 10. [Distribution of one of the ascitic fluid antigens of ovarian cancer patients in malignant tumors of the stomach and intestines].
    Sergeeva NS; Vasil'ev MIu; Kovalenko TI; Sokolova NV; Avdeev GI
    Eksp Onkol; 1989; 11(2):35-7. PubMed ID: 2661204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of C-reactive protein in autologous plasma of cancer patients and choline phosphate in lymphocyte responses to phytohemagglutinin.
    Oishi N; Torikawa C; Ochiai H; Hokama Y
    J Reticuloendothel Soc; 1973 Sep; 14(3):242-9. PubMed ID: 4200874
    [No Abstract]   [Full Text] [Related]  

  • 12. [Detection of gastric cancer associated antigens in ascitic and pleural fluid for ascertaining the nature of the exudate].
    Zhang JR; Zhang XY; Chen XT
    Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):729-30, 768. PubMed ID: 2636090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired cell-mediated immunity in patients with cancer.
    Buda JA; Suciu-Foca N; Reemtsma KB
    Surg Forum; 1974; 25(0):89-91. PubMed ID: 4548221
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte sensitivity and cellular immunity in neoplasia.
    Faguet GB; Balcerzak SP; Lobuglio AF
    Biomedicine; 1973 Feb; 19(2):43-7. PubMed ID: 4731978
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunohistochemical study of one of ascitic fluid antigens in patients with ovarian cancer using normal and tumor tissues].
    Sergeeva NS; Vasil'ev MIu; Sokolova NV; Avdeev GI
    Eksp Onkol; 1988; 10(1):20-2. PubMed ID: 3131099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity.
    Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM
    Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on specificity of cell-mediated immunity to human tumors.
    Takasugi M; Mickey MR; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1527-38. PubMed ID: 4140237
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired responsiveness of lymphocytes and serum-inhibitory factors in patients with cancer.
    Suciu-Foca N; Buda J; McManus J; Thiem T; Reemtsma K
    Cancer Res; 1973 Oct; 33(10):2373-7. PubMed ID: 4270240
    [No Abstract]   [Full Text] [Related]  

  • 19. [In vitro studies of autologous and allogeneic recognition in patients with gastric and colorectal adenocarcinoma].
    Machado I; Cabrera L; Anderson C; Meilijson O; Pérez L; Bianco N
    G E N; 1985; 39(1):1-19. PubMed ID: 2939005
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
    Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
    Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.